CARLA NIX: Open Payments
NPI 1164656294 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,887 in 98 payments from 18 companies in 2025. Trend: 2023 $712 · 2024 $1,917 · 2025 $1,887
Food & beverage: $1,712Education: $175
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 21 | $404 |
| ABBVIE INC. | 18 | $234 |
| SpringWorks Therapeutics, Inc. | 5 | $150 |
| UCB, Inc. | 7 | $130 |
| Lilly USA, LLC | 10 | $128 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $95 |
| BioWound Solutions, Inc. | 3 | $88 |
| Organon LLC | 8 | $85 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $77 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, GOMEKLI, Bimzelx, TALTZ, bio-ConneKt, NEMLUVIO.
Industry payments across AR — which companies pay providers there.
